(Q34357949)

1 August 2017

title

Subjective and objective assessment of enalapril in primary Raynaud's phenomenon (English)

1 reference

1 August 2017

1 reference

Challenor VF

1

1 reference

1 August 2017

Waller DG

2

1 reference

1 August 2017

Hayward RA

3

1 reference

1 August 2017

Griffin MJ

4

1 reference

1 August 2017

Roath OS

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 1991

1 reference

British Journal of Clinical Pharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

31

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

477-480

1 reference

Long-term experience with captopril in severe hypertension

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

Clinical and rheological effects of nifedipine in Raynaud's phenomenon

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

Treatment of Raynaud's phenomenon with captopril

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

The two-period cross-over clinical trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368337

Captopril in various forms of severe therapy-resistant hypertension

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB05565.X

21 January 2018

1 reference

12 December 2020

Enalapril in Raynaud's phenomenon

1 reference

PubMed

12 December 2020

[Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study]

1 reference

PubMed

12 December 2020

Treatment of Raynaud's syndrome with captopril

1 reference

PubMed

12 December 2020

10.1111/J.1365-2125.1991.TB05565.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference